PhenomeX

Industry

  • Services
  • Biotechnology
    • Nanotechnology, Chips, etc.
    • Gene Therapy, Cell Therapy
    • Drug Discovery Technologies
      • Genomics-Proteomics
    • Synthesis Technologies, Production Processes
    • Large Molecule
      • Antibodies
  • Research, Analytical Equipment & Supplies
  • Pharmaceuticals

Other Names/Subsidiaries

  • Berkeley Lights Inc.
  • IsoPlexis
See more in Biomedtracker

Latest on PhenomeX

Scrip

Otsuka Expands Ocular Gene Therapy Interests Through ShapeTX Deal

 
• By Lisa Takagi

Otsuka Pharmaceutical Co. Ltd. has teamed up Seattle, US-based biotech Shape Therapeutics, Inc. (ShapeTX) to further expand its R&D capabilities related to gene therapies for eye disorders. The up

Scrip

J.P. Morgan Extras: Pandemic Impact on Launch, Production, Development And More

 
• By Scrip Team

Lilly Will Carry Forward Travel Cost Savings, Clinical Trial Efficiencies Eli Lilly and Company chief financial officer Joshua Smiley said in an interview with Scrip that “there are some long-term

Medtech Insight

Financing: Q3 Roundup Shows Fall In Device Company Activity But A Rise In IVDs

 
• By Deanna Kamienski and Maureen Riordan

Third-quarter device financing activity reached $3.3bn, a significant drop from Q2’s $9.5bn, although 45% of the Q2 dollars can be attributed to two billion-dollar plus transactions: Stryker Corporat

Scrip

Finance Watch: One Week Of IPOs Total $818.2m

 
• By Mandy Jackson

Relay Therapeutics, Inc. had the third-largest biopharmaceutical initial public offering in the US in 2020 when it sold 20 million shares at $20 each to gross $400m. It was the first of four IPOs by